{
    "root": "2f720f76-1728-e099-e063-6294a90ac35b",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "calcium acetate",
    "value": "20250303",
    "ingredients": [
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L"
        },
        {
            "name": "BUTYL ALCOHOL",
            "code": "8PJ61P6TS3"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "CROSPOVIDONE (120 .MU.M)",
            "code": "68401960MK"
        },
        {
            "name": "CALCIUM ACETATE",
            "code": "Y882YXF34X"
        }
    ],
    "indications": "calcium acetate capsule phosphate binder indicated reduction serum phosphorus patients end stage renal disease . ( 1 )",
    "contraindications": "starting dose 2 capsules meal . ( 2 ) titrate dose every 2 3 weeks acceptable serum phosphorus level reached . patients require 3 4 capsules meal . ( 2 )",
    "warningsAndPrecautions": "calcium acetate capsules , usp blue opaque capsules imprinted `` hp 531 `` oral containing 667 mg calcium acetate ( anhydrous ca ( ch3coo ) 2 ; mw=158.17 grams ) equal 169 mg ( 8.45 meq ) calcium . ndc : 70518-4299-00 packaging : 30 1 blister pack storage : store 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15 30\u00b0c ( 59 86\u00b0f ) [ usp controlled room temperature ] . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "patients hypercalcemia .",
    "indications_original": "Calcium acetate capsule is a phosphate binder indicated for the reduction of serum phosphorus in patients with end stage renal disease. ( 1 )",
    "contraindications_original": "Starting dose is 2 capsules with each meal. ( 2 ) Titrate the dose every 2 to 3 weeks until acceptable serum phosphorus level is reached. Most patients require 3 to 4 capsules with each meal.( 2 )",
    "warningsAndPrecautions_original": "Calcium Acetate Capsules, USP are blue opaque capsules imprinted with \"HP 531\" for oral administration containing 667 mg calcium acetate (anhydrous Ca(CH3COO)2; MW=158.17 grams) equal to 169 mg (8.45 mEq) calcium.\n                  \n                  NDC: 70518-4299-00\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  \n                  STORAGE:\u00a0 Store at 25\u00b0C (77\u00b0F); excursions permitted to 15 to 30\u00b0C (59 to 86\u00b0F) [See USP Controlled Room Temperature].\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "Patients with hypercalcemia."
}